| Structure | Chemical Name | CAS | MF |
|
Boc-N-Me-Ser-OH
|
101772-29-6
|
C9H17NO5
|
|
4-Hexyloxybenzamide
|
101772-33-2
|
C13H19NO2
|
|
4-((((Aminoiminomethyl)amino)acetyl)amino)-N-(2-(((3-amino-3-iminoprop yl)amino)carbonyl)-1-methyl-1H-imidazol-4-yl)-1-methyl-1H-imidazole-2- carboxamide sulfate (1:1)
|
101772-43-4
|
C16H26N12O7S
|
|
[5-[[5-(2-carbamimidoylethylcarbamoyl)-1-methyl-pyrrol-3-yl]carbamoyl] -1-methyl-pyrrol-3-yl]carbamoylmethyl-triethyl-azanium chloride hydroc hloride
|
101772-45-6
|
C23H37N8O3.ClH.Cl
|
|
[5-[[5-(2-carbamoylethylcarbamoyl)-1-methyl-pyrrol-3-yl]carbamoyl]-1-m ethyl-pyrrol-3-yl]carbamoylmethyl-trimethyl-azanium chloride
|
101772-50-3
|
C20H30ClN7O4
|
|
[5-[[5-[2-(amino-azaniumylidene-methyl)ethylcarbamoyl]-1-methyl-pyrrol -3-yl]carbamoyl]-1-methyl-pyrrol-3-yl]carbamoylmethyl-trimethyl-azaniu m
|
101772-52-5
|
C20H32N8O3+2
|
|
6-methoxy-2-Pyridinepropanol
|
101773-68-6
|
C9H13NO2
|
|
6-Bromoindole-3-carboxylic acid
|
101774-27-0
|
C9H6BrNO2
|
|
3-Chloro-4-hydroxyisoquinoline
|
101774-33-8
|
C9H6ClNO
|
|
5-Chloroquinolin-4(1H)-one
|
101774-49-6
|
C9H6ClNO
|
|
2-Norbornanecarboxylic acid, 2-chloro-
|
101774-57-6
|
C8H11ClO2
|
|
Benzothiazole, 2-(3-aminopropylthio)- (6CI)
|
101774-85-0
|
C10H12N2S2
|
|
6,7-Dimethoxy-1-propyl-1,2,3,4-tetrahydroisoquinoline hydrochloride
|
101776-23-2
|
C14H22ClNO2
|
|
Ethyl 1-cyclohexyl-5-hydroxy-2-methyl-1H-indole-3-carboxylate
|
101782-20-1
|
C18H23NO3
|
|
Benzene, 1,1''-(1,6-hexanediyl)bis[4-bromo-
|
101783-96-4
|
C18H20Br2
|
|
CAY10704
|
101784-44-5
|
C18H20Cl2N2
|
|
2-diethylamino-N,N-diphenyl-acetamide
|
101784-86-5
|
C18H22N2O
|
|
2,3-dibenzylbutane-1,4-diol
|
101787-58-0
|
C18H22O2
|
|
3,3',5,5'-Tetramethylbenzil
|
101789-41-7
|
C18H18O2
|
|
m-PEG7-CH2COOH
|
101791-31-5
|
C17H34O10
|
|
2-(4'-Chloro-biphenyl-4-yl)-benzothiazole
|
101798-15-6
|
C19H12ClNS
|
|
4-(4-Chlorophenylsulfanyl)piperidine hydrochloride
|
101798-64-5
|
C11H15Cl2NS
|
|
4-Phenylsulfanylpiperidine hydrochloride
|
101798-65-6
|
C11H15NS
|
|
4-Phenylsulfanylpiperidine hydrochloride
|
101798-66-7
|
C11H16ClNS
|
|
4-(2-Chlorophenylsulfanyl)piperidine hydrochloride
|
101798-68-9
|
C11H15Cl2NS
|
|
4-(4-Fluorophenylsulfanyl)piperidine hydrochloride
|
101798-76-9
|
C11H15ClFNS
|
|
hemoglobin A2 Honai
|
101800-48-0
|
|
|
hemoglobin A2 Yokoshima
|
101800-49-1
|
|
|
hemoglobin F-Cobb
|
101800-50-4
|
|
|
hemoglobin North Chicago
|
101800-51-5
|
C37H50N4O9S
|
|
enomelanin
|
101802-09-9
|
C43H54N4O8S
|
|
2'-Deoxy-4-desmethylwyosine
|
101803-00-3
|
C13H15N5O4
|
|
N2-Ethyl-2'-deoxyguanosine
|
101803-03-6
|
C12H17N5O4
|
|
5-Iodo-2-methoxypyrimidine
|
101803-06-9
|
C5H5IN2O
|
|
Pyrimidine, 2-methoxy-5-(1-propynyl)- (9CI)
|
101803-07-0
|
C8H8N2O
|
|
2,4,6-Triisopropylbenzenesulfonyl fluoride
|
101803-62-7
|
C15H23FO2S
|
|
(1-Amino-1,2-dimethylpropyl)phosphonic acid hydrate
|
101804-01-7
|
C5H14NO3P
|
|
1H-1,2,4-Triazole,1-[[(1,1-dimethylethyl)dimethylsilyl]methyl]-(9CI)
|
101804-05-1
|
C9H19N3Si
|
|
1H-1,2,4-Triazole,1-[[tris(1-methylethyl)silyl]methyl]-(9CI)
|
101804-56-2
|
C12H25N3Si
|
|
3,5-Pyridinedicarbonitrile, 2-amino-4-methyl-
|
101810-71-3
|
C8H6N4
|
|
N,N',N'',N'''-(1,5-pentanediylidene)tetrakismethacrylamide
|
101810-92-8
|
C21H32N4O4
|
|
Siloxanes and Silicones, di-Me, 3-hydroxypropyl Me, Me 3-(oxiranylmethoxy)propyl, ethers with polyethylene-polypropylene glycol mono-Me ethers
|
101810-98-4
|
|
|
4,4''-Diamino-2,2''-disulfostilbene-N,N,N''N''-tetraacetic acid disodium salt
|
101812-47-9
|
C22H22N2O14S2
|
|
Piperazine, 1-(dimethoxymethyl)-
|
101814-69-1
|
C7H16N2O2
|
|
N-((9-acridinyl)-4-aminobutanoyl-tyrosyl-lysyl-lysyl-glycyl)-N'-(9-acridinyl)-1,3-diaminopropane
|
101817-45-2
|
|
|
5-bromo-8-hydroxy-3,4-dihydronaphthalen-1(2H)-one
|
101819-51-6
|
C10H9BrO2
|
|
2,4-Dichloro-3-ethyl-6-aminophenol hydrochloride
|
101819-99-2
|
C8H10Cl3NO
|
|
6-Methyl-imidazo [1,2-a] pyridine-3-acetic acid
|
101820-58-0
|
C10H10N2O2
|
|
IMidazo[1,2-a]pyridine-3-aceticacid,ethylester
|
101820-69-3
|
C11H12N2O2
|
|
15-Hydroxyabieta-7,13-dien-18-oic acid
|
101821-23-2
|
C20H30O3
|
|
AKOS BC-0547
|
101821-81-2
|
C14H22O2
|
|
Pyridine, 2,4-bis(chloromethyl)- (9CI)
|
101822-23-5
|
C7H7Cl2N
|
|
Methanamine, N-[1-(2,5-dimethyl-1H-pyrrol-3-yl)ethylidene]- (9CI)
|
101822-52-0
|
C9H14N2
|
|
2-chloro-N-[3-(trifluoromethyl)benzyl]acetamide
|
101824-35-5
|
C10H9ClF3NO
|
|
AKOS B023239
|
101825-11-0
|
C12H19NO2
|
|
propan-2-yl({[4-(trifluoromethyl)phenyl]methyl})amine
|
101825-12-1
|
C11H14F3N
|
|
Butenafine hydrochloride
|
101827-46-7
|
C23H27N.ClH
|
|
Butenafine Impurity 4
|
101827-53-6
|
C23H28ClN
|
|
DesMethyl Butenafine Hydrochloride
|
101828-08-4
|
C22H26ClN
|
|
Butenafine
|
101828-21-1
|
C23H27N
|
|
10-DOXYL-nonadecane
|
101829-05-4
|
C23H46NO2*
|
|
2-Propenamide,N-2-benzothiazolyl-2-methyl-(9CI)
|
101830-95-9
|
C11H10N2OS
|
|
cholecystokinin 21
|
101831-07-6
|
C98H169N33O30S
|
|
Clazuril
|
101831-36-1
|
C17H10Cl2N4O2
|
|
Diclazuril
|
101831-37-2
|
C17H9Cl3N4O2
|
|
1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-isoquinoline, (8R,9S,10R ,13S,14S)-10,13-dimethyl-17-oxo-3-sulfooxy-1,2,3,4,7,8,9,11,12,14,15,1 6-dodecahydrocyclopenta[a]phenanthrene
|
101831-49-6
|
C39H49NO9S
|
|
5-Cyanotryptamine hydrochloride
|
101831-71-4
|
C11H12ClN3
|
|
2,2,2-Trifluoro-1-(5-nitro-3-indolyl)ethanone
|
101832-10-4
|
C10H5F3N2O3
|
|
N-(4-Chlorobenzyl)nonanamide
|
101832-14-8
|
C16H24ClNO
|
|
2-Oxazolamine,N-bicyclo[2.2.1]hept-2-yl-4,5-dihydro-(9CI)
|
101832-33-1
|
C10H16N2O
|
|
(S)-3-(Pyrrolidin-2-yl)pyridine hydrochloride
|
101832-65-9
|
C9H13ClN2
|
|
2,3-diMethyl-1H-Indol-7-aMine
|
101832-73-9
|
C10H12N2
|
|
5-Benzyloxy-[3-(2-dimethylaminoethyl)]indole hydrogenoxalate
|
101832-88-6
|
C21H24N2O5
|
|
N-(5,5-Dimethyl-2-oxotetrahydrofuran-3-yl)-5-nitro-3-furancarboxamide
|
101833-02-7
|
|
|
4,5-Dihydro-3-[2-hydroxy-3,3,3-trifluoro-2-(trifluoromethyl)propyl]-2(3H)-furanone
|
101833-16-3
|
|
|
Ethyl4,6-O-benzylidene-beta-D-galactopyranoside
|
101833-22-1
|
C15H20O6
|
|
BIS(INDENYL)VANADIUM(II)
|
101834-69-9
|
C18H14V
|
|
2,4-Dinitro-1-naphthol,sodiumsalt
|
101836-92-4
|
C10H6N2O5.2H2O.Na
|
|
ganglioside GD1alpha
|
101839-44-5
|
|
|
Dettox
|
101839-71-8
|
|
|
Occlusin
|
101839-93-4
|
|
|
hydroxyethyl methacrylate-methacrylic acid-ethyl methacrylate copolymer
|
101842-61-9
|
C16H26O7
|
|
9,12-Octadecadienoic acid (9Z,12Z)-, 1-hexyl-12-(isohexadecyloxy)-12-oxododecyl ester
|
101842-77-7
|
|
|
ASTRASIEVERSIANIN 15(RG)
|
101843-83-8
|
C46H76O17
|
|
astrasieversianin XI
|
101843-86-1
|
C48H78O18
|
|
1-[(2R,3R,4R,5R)-3,4-dibutoxy-5-(butoxymethyl)oxolan-2-yl]-1,2,4-triaz ole-3-carboxamide
|
101843-94-1
|
C20H36N4O5
|
|
N-Methyl-4-tert-butylbenzylaMine Hydrochloride
|
101846-35-9
|
C12H20ClN
|
|
Butenafine Impurity 13
|
101846-86-0
|
C23H25NO
|
|
Methyl 5-methylthio-1,2,4-thiadiazol-3-ylcarbamate
|
101848-19-5
|
C5H7N3O2S2
|
|
2-[[(2S)-2-[[(2S)-2-[[(2S,3R)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-am ino-4-methyl-pentanoyl]amino]-3-phenyl-propanoyl]amino]-3-methyl-butan oyl]amino]-3-methyl-butanoyl]amino]-3-hydroxy-butanoyl]amino]-4-methyl -pentanoyl]amino]-3-methyl-butanoyl]amino]acetic acid
|
101848-26-4
|
C42H70N8O10
|
|
peptide II (Aplysia)
|
101849-76-7
|
C56H88N14O20S
|
|
2H-Cyclopenta[b]furan-2-one,hexahydro-4-[(1E,3S,5S)-5-Methyl-3-[(tetrahydro-2H-pyran-2-yl)oxy]-1-nonen-1-yl]-5-[(tetrahydro-2H-pyran-2-yl)oxy]-, (3aR,4R,5R,6aS)-
|
101849-78-9
|
C27H44O6
|
|
(4-Chloro-naphthalen-1-yl)-hydrazine hydrochloride
|
101851-40-5
|
C10H9ClN2
|
|
2-(2-Anilinovinyl)-3-(4-sulfobutyl)benzoxazolium betaine
|
101852-89-5
|
C19H20N2O4S
|
|
Decanoic acid, 5-hydroxy-, methyl ester
|
101853-47-8
|
C11H22O3
|
|
Boc-D-Dab(Z)-OH dcha
|
101854-42-6
|
C17H24N2O6.C12H23N
|
|
H-D-Ala-Gly-NH2 HCl
|
101854-68-6
|
C5H12ClN3O2
|
|
5,5'-Bis(trifluoromethyl)-2,2'-dichlorobenzophenone
|
101855-91-8
|
C15H6Cl2F6O
|
|
2-Difluoromethoxyphenyl isothiocyanate
|
101856-90-0
|
C8H5F2NOS
|
|
1,2,5-Selenadiazole-3-carbonylchloride(9CI)
|
101857-31-2
|
C3HClN2OSe
|